## **Trustees’ Annual Report for the period** **From 31-12-22 To 31-12-23** ## **Charity name: Childhood Cancer Research Trust** ## **Charity registration number: 1196005** ## **Objectives and Activities** ||SORP reference|| |---|---|---| |Summary of the purposes of
the charity as set out in its
governing document|Para 1.17|To relieve sickness and preserve and
protect health for the public benefit by
providing funding for childhood cancer
research projects primarily in the UK in
order to improve outcomes for childhood
cancer suffers by finding safer and more
effective treatments at a fast rate.| |Summary of the main
activities in relation to those
purposes for the public
benefit, in particular, the
activities, projects or
services identified in the
accounts.|Para 1.17 and
1.19|The Childhood Cancer Research Trust has
primarily funded The Concorde Initiative to
explore the use of natural compounds in
paediatric cancer treatment.
This grant supports crucial research to
consolidate the full scope of the
possibilities for the use of Natural
Compounds in cancer care,
directly aligning with our mission and
offering significant potential benefits to
children with cancer globally.| |Statement confirming
whether the trustees have
had regard to the guidance
issued by the Charity
Commission on public
benefit|Para 1.18|In directing our efforts and resources, the
trustees of The Childhood Cancer
Research Trust have diligently considered
and adhered to the guidance issued by the
Charity Commission regarding public
benefit. This guidance underscores the
importance of ensuring that all charitable
activities directly contribute to the public
good, in line with our charitable objects.
This fiscal year, our commitment to
maximizing public benefit was exemplified
through a strategic grant to The Concorde
Initiative, which focuses on researching the
use of natural compounds in paediatric
cancer treatment. By funding this
pioneering research, we aim to forge new
pathways in cancer care that could
significantly improve treatment options for
children. Importantly, all funds raised have
been allocated directly to this research,
with no overheads, salaries, or
administration costs deducted, ensuring| that every pound is directly applied to advancing this vital work. The insights produced by The Concorde Initiative this year have shown promising potential to enhance cancer care for children, aligning with our mission and the Charity Commission's expectations for public benefit. **Additional information (optional)** You may choose to include further statements where relevant about: SORP reference Para 1.38 Policy on grant making Para 1.38 Policy on social investment including program related investment Para 1.38 Contribution made by volunteers Other ## **Achievements and Performance** **----- Start of picture text -----**
SORP reference
**----- End of picture text -----**
|**Achievements and Performance**|**Achievements and Performance**|**Achievements and Performance**| |---|---|---| |SORP reference||| |||| |Summary of the main
achievements of the charity,
identifying the difference the
charity’s work has made to
the circumstances of its
beneficiaries and any wider
benefits to society as a
whole.|Para 1.20|This year, The Childhood Cancer Research
Trust has taken the first step in making a
key contribution to the progression of
cancer research by awarding a £40,000
grant to The Concorde Initiative. This
funding was directed towards
groundbreaking research on the potential
for the use of natural compounds for
patients with cancer. The Concorde
Initiative has successfully generated and
documented significant new knowledge in
this area, which aligns with our
commitment to innovation in paediatric
cancer treatment.
Our efforts are ultimately directed towards
fulfilling our mission to improve the health
outcomes of children with cancer and
contribute to the broader societal goal of
making cancer treatment safer and more
effective.| |**Additional information (optional)**
You may choose to include further statements|**Additional information (optional)**
You may choose to include further statements|where relevant about:| |---|---|---| |Achievements against
objectives set|Para 1.41|| |Performance of fundraising
activities against objectives
set|Para 1.41|| |Investment performance
against objectives|Para 1.41|| |Other||| ## **Financial Review** **----- Start of picture text -----**
Review of the charity’s Para 1.21 The Childhood Cancer Research Trust
financial position at the end raised £ 61,944 in the year to 2023. The
of the period significant legacy donation of £40,000
received was specified for the work of The
Concorde Initiative and fully awarded to it.
This grant supported our pivotal research
into developing kinder and more effective
treatments for children with cancer. While
our available funds are currently low, this
investment aligns with our strategic
commitment to advancing medical research
and demonstrates effective use of donor
contributions for designated purposes.
After direct fund raising costs and the grant
allocation, £19,025 remains which will be
directed towards the next phase of The
Concorde Initiative.
Statement explaining the Para 1.22 Reserve Policy Statement
policy for holding reserves Our charity does not maintain a reserve
stating why they are held fund as the charity has no overheads,
salaries or other ongoing expenses. Our
aim is to maximise investment in creating
the knew knowledge required to fulfil our
mission while also prudently managing
cashflow.
Amount of reserves held Para 1.22 n/a
Reasons for holding zero Para 1.22 n/a
reserves
Details of fund materially in Para 1.24 n/a
deficit
Explanation of any Para 1.23 n/a
uncertainties about the
charity continuing as a going
concern
**----- End of picture text -----**
## **Additional information (optional)** You may choose to include further statements where relevant about: |**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:|**Additional information (optional)**
You may choose to include further statements where relevant about:| |---|---|---| |||| |The charity’s principal
sources of funds (including
any fundraising)|Para 1.47|| |Investment policy and
objectives including any
social investment policy
adopted|Para 1.46|| |A description of the principal
risks facing the charity|Para 1.46|| Other ## **Structure, Governance and Management** **----- Start of picture text -----**
Description of charity’s
trusts:
Type of governing document Para 1.25 Constitution of a Charitable Incorporated
(trust deed, royal charter) Organisation
How is the charity Para 1.25 CIO
constituted?
(e.g unincorporated
association, CIO)
**----- End of picture text -----**
|**Structure, Governance and Management**|**Structure, Governance and Management**|**Structure, Governance and Management**| |---|---|---| |Description of charity’s
trusts:||| |Type of governing document
(trust deed, royal charter)
Para 1.25
Constitution of a Charitable Incorporated
Organisation||| |How is the charity
constituted?
(e.g unincorporated
association, CIO)
Para 1.25
CIO||| |Trustee selection methods
including details of any
constitutional provisions e.g.
election to post or name of
any person or body entitled
to appoint one or more
trustees|Para 1.25|Constitutional Provisions
According to our constitution, trustees are
selected through a comprehensive
evaluation process that assesses each
candidate's alignment with our foundational
goals and strategic needs. Candidates are
reviewed based on their:

Commitment to our cause:
Demonstrating a passion for
advancing medical research and
improving healthcare outcomes.

Innovative thinking: Ability to
contribute new ideas and
approaches for transforming
medical research and patient care.

Medical or NHS background:
Although not mandatory, experience
in healthcare sectors is considered
a significant asset.

Diversity of experience: Bringing
varied professional and personal
backgrounds to provide a wide
range of viewpoints and expertise.
The selection process is carried out by
existing trustees with advice sought from
our Board of Consultants as necessary.
The final appointment of trustees is made
after a majority vote by the existing board
members.
This process is designed to ensure that our
Board of Trustees is equipped with the
expertise, vision, and diversity required to
guide our charity effectively in its mission.| ## **Additional information (optional)** You may choose to include further statements where relevant about: |Policies and procedures
adopted for the induction
and training of trustees|Para 1.51|| |---|---|---| |The charity’s organisational
structure and any wider
network with which the
charity works|Para 1.51|| **----- Start of picture text -----**
The Concorde Initiative, owned by Dr Alex
Concorde, is closely linked with the
Relationship with any Para 1.51 Childhood Cancer Research Trust due to
related parties the charity’s focused support of Dr
Concorde’s research. Dr Concorde has
been appointed Medical Director of the
charity in order to spearhead the translation
of the CCRT objects into action by
mediating between the mission of the
CCRT and the actual execution of the
charitable objects through her work at TCI,
thereby ensuring the research activities
align effectively with the strategic goals of
the Childhood Cancer Research Trust.
The relationship is managed under strict
governance practices to avoid any conflicts
of interest, ensuring that our collaboration
is transparent and maintains the highest
integrity. This arrangement enhances our
capacity to drive forward innovations in the
development of potential treatment and
care for children with cancer to a far greater
degree than might otherwise be possible.
Other
**----- End of picture text -----**
## **Reference and Administrative details** **----- Start of picture text -----**
Charity name Childhood Cancer Research Trust
Other name the charity uses CCRT
Registered charity number 1196005
Charity’s principal address 14 Chester Street
Oxford
OX4 1SL
**----- End of picture text -----**
**Names of the charity trustees who manage the charity** **----- Start of picture text -----**
Dates acted if not for whole Name of person (or body) entitled
Trustee name Office (if any)
year to appoint trustee (if any)
1 Oonah Buist Chair
2 Trina Wright Trustee
Georgina Perceval Trustee
3
Maxwell
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
**----- End of picture text -----**
– Corporate trustees names of the directors at the date the report was approved **Director name** Name of trustees holding title to property belonging to the charity **Trustee name Dates acted if not for whole year** ## **Funds held as custodian trustees on behalf of others** Description of the assets held in this capacity Name and objects of the charity on whose behalf the assets are held and how this falls within the custodian charity’s objects Details of arrangements for safe custody and segregation of such assets from the charity’s own assets ## **Additional information (optional)** ## **Names and addresses of advisers (Optional information)** **----- Start of picture text -----**
Type of Name Address
adviser
Accountant Business Control Red Lion Yard,
Odd Down,
Bath, Somerset,
BA2 2PP,
**----- End of picture text -----**
**Name of chief executive or names of senior staff members (Optional information)** ## **Exemptions from disclosure** Reason for non-disclosure of key personnel details ## **Other optional information** ## **Declarations** **The trustees declare that they have approved the trustees’ report above.** **Signed on behalf of the charity’s trustees** **Signature(s) Full name(s)** Oonah Buist **Position (eg Secretary,** Chair **Chair, etc)** **----- Start of picture text -----**
Date
**----- End of picture text -----**
**Charity Name No (if any) Receipts and payments accounts CC16a For the period** Period start date Period end date **To from** Jan-23 Dec-23 **----- Start of picture text -----**
Section A Receipts and payments
Unrestricted Restricted Endowment
Total funds Last year
funds funds funds
to the nearest
to the nearest £ to the nearest £ to the nearest £ to the nearest £
£
A1 Receipts
Woo Commerce Donations 7,009 - - 7,009 815
Paypal Donations 2,351 - - 2,351 -
Cash Donations 379 - - 379 -
Direct Individual Donations 50,752 - - 50,752 70
Sales - others 1,453 - - 1,453 100
- - - - -
- - - - -
- - - - -
Sub total (Gross income for
61,944 - - 61,944 985
AR)
A2 Asset and investment sales,
(see table).
- - - -
- - - - -
Sub total - - - - -
Total receipts 61,944 - - 61,944 985
A3 Payments
Stripe Charges 132 - - 132 28
Events - direct costs 2,782 - - 2,782 -
Grant 40,000 - - 40,000 -
Postage 5 - - 5 -
- - - - -
- - - - -
- - - - -
- - - - -
- - - - -
Sub total [ 42,919 ] - - 42,919 28
A4 Asset and investment
purchases, (see table)
- - - -
- - - -
Sub total [ - ] - - - -
Total payments 42,919 - - 42,919 28
Net of receipts/(payments) 19,025 - - 19,025 957
A5 Transfers between funds - - - - -
A6 Cash funds last year end - - - - -
Cash funds this year end 19,025 - - 19,025 957
**----- End of picture text -----**
CCXX R1 accounts (SS) 01/11/2024 1 |**Categories**
Signed by one or two trustees on
behalf of all the trustees
**B1 Cash funds**
**B2 Other monetary assets**
**B4 Assets retained for the**
**charity’s own use**
**B5 Liabilities**
**B3 Investment assets**|Signature
**Details**
**Details**
**Details**
**Details**
**_Total cash funds_**
(agree balances with receipts and payments
account(s))
**Details**|**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
Agreement Error
OK
**Unrestricted**
**funds**
**Restricted**
**funds**
**to nearest £**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**asset belongs**
**Cost (optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**Fund to which**
**liability relates**
**Amount due**
**(optional)**
**-**
**-**
**-**
**-**
**-**
Print Name
Oonah Buist|**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
OK
**Endowment**
**funds**
**to nearest £**
**-**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**Current value**
**(optional)**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**-**
**When due**
**(optional)**
Date of
approval
31/10/2024| |---|---|---|---| CCXX R2 accounts (SS) 01/11/2024 2 CHARITY COMMISSION FOR ENGLAND AND WALES Independent examiner's report on the accounts Section A Indopendent Examiner's Report Report to thè trustees ChildlKJod Cancer Research Trust On #ecounts lor tho yur •nded 3111 Oecember 2023 Charity rM> (ff •nyl 1196005 Set out on pages I reFx)rt lo the truslees on my examination of the accounts of the atthie chanty (Ihe Trust") for the year ended 3111J2023. R•8ponilbllltl¢• and bo81s of report As the charity's trustees, you are resFonsible for the preparalKJn of ihe accounts in accordance wtth the requirements of the Chariiies Act 2011 lllhe Act"). I report in respecl of my examinalkm ol tho Tru8t's accounts cttniad out undef SeCt￿n 145 of Ihe 2011 Act and in carying out my 8xaminalion. I have foltowed all the applubbe Direclw)ns givén ty thé Charty Commiss ts￿lef section 149511bl ol the Act. Independent I have comthled ry ex8min81ion. I confim that no materi81 matters have •xamlner's slatement come lo my attenlK*n in connection wrth Ihe examination lolher than Ihal disclosed ') which gives mo caus8 to b•lK*ve that In. any maternl respect.. the aCc￿￿tIng records **re ncrt kept kn accordancè with 88Ction 130 of the Charities Act. Of the x¢ounl$ dtd nol accord with the accountlng records: or the accounts did not compty wrth the applicab￿ requirements concerning the lo￿ and conlenl of accounts sel oul in the Chaiitles {Accounls and RepJrt$l Regutalion5 2008 other than any requiren*nt that Ihe accounts give a Irue and fatr, v*w which is not a matter consKlered as part ol an independent examination. I havo no ¢oncem$ and have come acro$$ no other matters In conneclion with the examination lo whKh atlenlion $h¢)uid be dr8wn in this Tep)rt in order to enable a proper underslan(Ilng of Ihe acccwnls lo be reacheo. Dats: 6 November 2024 Slgned: Nam•: Richard Starkey Relevant profes$lonal quallficitionlsl or body (if any): A.C.fvl.A Addre4•: Red Lion Yard. Odd Dthvn. Bath, BA2 2PP IER Oct 2018 Section B Disclosure Onty complete il the examiner needs lo highlight material mallers ol con￿rn 18ee CC32, Independent examinats'on of charty accounts.. directM)n8 8rKI gumlance for examinetsl. Give her• brl•f d•tall• ol any items that th• •xaminer wlshes to dlsclose. IER Oct 2018